Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | KRAS |
| Upstream (Parents) |
|---|
| (<<) BMPR2 → KRAS |
| (<<) CBL → KRAS |
| (<<) ENC1 → KRAS |
| (<<) NCOA3 → KRAS |
| (<<) NFAT5 → KRAS |
| (<<) SLC20A1 → KRAS |
| (<<) SMAD5 → KRAS |
| (<<) WASF2 → KRAS |
| Downstream (Children) |
|---|
| KRAS → CAMKK2 (>>) |
| KRAS → CASKIN1 (>>) |
| KRAS → CCND1 (>>) |
| KRAS → CCND3 (>>) |
| KRAS → CDK6 (>>) |
| KRAS → COIL (>>) |
| KRAS → DYNC1LI2 (>>) |
| KRAS → EFNB2 (>>) |
| KRAS → EMG1 (>>) |
| KRAS → EML4 (>>) |
| KRAS → GRIN2D (>>) |
| KRAS → HSPA4 (>>) |
| KRAS → ITPR2 (>>) |
| KRAS → KLHDC5 (>>) |
| KRAS → LYAR (>>) |
| KRAS → MAP2K3 (>>) |
| KRAS → NEUROG1 (>>) |
| KRAS → NFKBIZ (>>) |
| KRAS → NRIP1 (>>) |
| KRAS → NRIP3 (>>) |
| KRAS → PDPK1 (>>) |
| KRAS → PNPLA3 (>>) |
| KRAS → PPP2R5C (>>) |
| KRAS → PRKCI (>>) |
| KRAS → SET (>>) |
| KRAS → SOX3 (>>) |
| KRAS → TCF4 (>>) |
| KRAS → TNFRSF10A (>>) |
| KRAS → WBP4 (>>) |
